Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Other Non-Current Assets (2018 - 2026)

TransMedics has reported Other Non-Current Assets over the past 8 years, most recently at $500000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 140.38% year-over-year to $500000.0; the TTM value through Dec 2025 reached $500000.0, up 140.38%, while the annual FY2025 figure was $500000.0, 140.38% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $500000.0 at TransMedics, up from $226000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $750000.0 in Q1 2023 and troughed at $59000.0 in Q2 2023.
  • A 5-year average of $419350.0 and a median of $500000.0 in 2021 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: skyrocketed 8233.33% in 2021 and later tumbled 88.2% in 2023.
  • Year by year, Other Non-Current Assets stood at $500000.0 in 2021, then changed by 0.0% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023, then tumbled by 58.4% to $208000.0 in 2024, then soared by 140.38% to $500000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for TMDX at $500000.0 in Q4 2025, $226000.0 in Q3 2025, and $500000.0 in Q2 2025.